Probiotic supplement for Alzheimer's patients

Investigating the effect of native engineered probiotic supplement on cognitive function and quality of life of Alzheimer's patients

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240410061465N2

Enrollment

Registered

2024-04-26

Start date

2024-05-21

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's disease. Alzheimer's disease

Interventions

Intervention 1: Intervention group: Patients with mild to moderate Alzheimer's are over 60 years old, diagnosed by a neurologist, with a small mental state examination score between 10 and 24, the dos

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: People with mild to moderate Alzheimer's

Exclusion criteria

Exclusion criteria: Patient non-cooperation during treatment Possible death of the patient during the study according to the nature of the disease

Design outcomes

Primary

Measure	Time frame
Quality of Life. Timepoint: before the start of the study and after 6 weeks and the end of the study. Method of measurement: questionnaire.;Cognitive performance of people. Timepoint: Start and end of study. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Maleki-Kakelar

Oroumia University of Medical Sciences

Maleki.hadi@umsu.ac.ir+98 44 3348 6165

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026